Aethlon Medical Inc AEMD

$5.29 -0.29 (-5.20%)

Valuation

Market cap
3,968,000
Revenue TTM
$0
Net income TTM
$-7,150,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
26,400
Avg volume
1,997,118
Day's range
$5.21 – $5.64
Shares out
711,000
Stochastic %K
12%
Beta
1.27
Analysts
Hold
Price target
$3.25

Price

Company profile

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.

Industry
Medical Devices
Sector
Healthcare
Phone
619 941 0360
Website
https://www.aethlonmedical.com
Address
11555 Sorrento Valley Road, Suite 203, San Diego, United States

Latest news